Teva Pharmaceutical (NYSE:TEVA) is a selection for the real-money Inflation-Protected Income Growth portfolio. Like any investment, it needs to be reviewed from time to time to see whether it still deserves a spot in the portfolio. In the brief following video, portfolio manager Chuck Saletta reviews its valuation, balance sheet, and dividends and decides whether to hold on to the stock or let it go.
To follow the IPIG portfolio as buy and sell decisions are made, watch Chuck's article feed by clicking here. To join The Motley Fool's free discussion board dedicated to the IPIG portfolio, simply click here.
Chuck Saletta owns shares of Teva Pharmaceutical Industries. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.